Pharmafile Logo

B2B sales

- PMLiVE

Study reveals Takotsubo syndrome patients failed by current cardiovascular treatments

Takotsubo syndrome patients were found to be as vulnerable to dying as heart attack patients

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Impetus Digital

- PMLiVE

Stirred announces Stirred Well, a new wellness offering

The move will extend the agency’s reach into the preventative, everyday health space

Unlock possibilities: A Medical Affairs strategy fit for the future

Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.

OPEN Health

- PMLiVE

GSK to expand respiratory pipeline with $1.4bn Aiolos Bio acquisition

The deal includes a monoclonal antibody ready to enter phase 2 development for asthma

- PMLiVE

Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis

More than 26 million people in the US are affected by the inflammatory skin disease

- PMLiVE

Merck granted FDA approval for Keytruda combination in cervical cancer

The decision marks the third FDA-approved indication for Keytruda in cervical cancer

- PMLiVE

Pfizer’s COVID-19 antiviral Paxlovid recommended by NICE for expanded use

The latest guidance will mean an estimated 5.3 million people will be eligible to access Paxlovid

- PMLiVE

UK national study supports whole genome sequencing in standard cancer care

The trial combined data from the UK’s 100,000 Genomes Project and NHS records

- PMLiVE

Study identifies hundreds of priority targets for cancer drug discovery

Researchers identified 370 priority drug candidates across 27 types of cancer

Why Words Matter

Why Words Matter: Person-first language in the age of identity

We take a look at why the words we use in medcomms matter and examine the use of patient-first language

Mednet

Home appointment with a patient and his doctor

Advancing digital engagement in pharma and healthcare: 2024 focus areas

6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users

Graphite Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links